74 related articles for article (PubMed ID: 1552341)
1. Technetium- and rhenium-labeled progestins: synthesis, receptor binding and in vivo distribution of an 11 beta-substituted progestin labeled with technetium-99 and rhenium-186.
DiZio JP; Anderson CJ; Davison A; Ehrhardt GJ; Carlson KE; Welch MJ; Katzenellenbogen JA
J Nucl Med; 1992 Apr; 33(4):558-69. PubMed ID: 1552341
[TBL] [Abstract][Full Text] [Related]
2. Progestin-rhenium complexes: metal-labeled steroids with high receptor binding affinity, potential receptor-directed agents for diagnostic imaging or therapy.
DiZio JP; Fiaschi R; Davison A; Jones AG; Katzenellenbogen JA
Bioconjug Chem; 1991; 2(5):353-66. PubMed ID: 1790176
[TBL] [Abstract][Full Text] [Related]
3. Progestin radiopharmaceuticals labeled with technetium and rhenium: synthesis, binding affinity, and in vivo distribution of a new progestin N2S2-metal conjugate.
O'Neil JP; Carlson KE; Anderson CJ; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 1994; 5(3):182-93. PubMed ID: 7918738
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics.
van Gog FB; Visser GW; Klok R; van der Schors R; Snow GB; van Dongen GA
J Nucl Med; 1996 Feb; 37(2):352-62. PubMed ID: 8667076
[TBL] [Abstract][Full Text] [Related]
5. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
6. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
Chao CC; Thomas TJ; Ebede P; Gallo MA; Thomas T
Cancer Res; 1991 Aug; 51(15):3938-45. PubMed ID: 1855211
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors.
Bigott HM; Parent E; Luyt LG; Katzenellenbogen JA; Welch MJ
Bioconjug Chem; 2005; 16(2):255-64. PubMed ID: 15769078
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and binding affinities of Re(I) and (99m)Tc(I)-containing 16alpha-substituted estradiol complexes: Models for potential breast cancer imaging agents.
Huang L; Zhu H; Zhang Y; Xu X; Cui W; Yang G; Shen YM
Steroids; 2010 Dec; 75(12):905-11. PubMed ID: 20493897
[TBL] [Abstract][Full Text] [Related]
9. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
10. Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Müller C; Schubiger PA; Schibli R
Nucl Med Biol; 2007 Aug; 34(6):595-601. PubMed ID: 17707798
[TBL] [Abstract][Full Text] [Related]
11. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
Uehara T; Jin ZL; Ogawa K; Akizawa H; Hashimoto K; Nakayama M; Arano Y
Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and biological evaluation of technetium(V) and rhenium(V) complexes of novel heterocyclic tetradentate N3S ligands.
Rajagopalan R; Grummon GD; Bugaj J; Hallemann LS; Webb EG; Marmion ME; Vanderheyden JL; Srinivasan A
Bioconjug Chem; 1997; 8(3):407-15. PubMed ID: 9177848
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of technetium and rhenium tricarbonyl complexes bearing the 4-nitrobenzyl moiety as potential bioreductive diagnostic radiopharmaceuticals. In vitro and in vivo studies.
Giglio J; Patsis G; Pirmettis I; Papadopoulos M; Raptopoulou C; Pelecanou M; León E; González M; Cerecetto H; Rey A
Eur J Med Chem; 2008 Apr; 43(4):741-8. PubMed ID: 17658668
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biodistribution studies of two novel radiolabeled estrone derivatives.
Enginar H; Unak P; Lambrecht FY; Biber Muftuler FZ; Medine EI
In Vivo; 2008; 22(1):93-100. PubMed ID: 18396789
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel progestin-rhenium conjugates as potential ligands for the progesterone receptor.
Wüst F; Skaddan MB; Leibnitz P; Spies H; Katzenellenbogen JA; Johannsen B
Bioorg Med Chem; 1999 Sep; 7(9):1827-35. PubMed ID: 10530930
[TBL] [Abstract][Full Text] [Related]
17. High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions.
van Gog FB; Visser GW; Stroomer JW; Roos JC; Snow GB; van Dongen GA
Cancer; 1997 Dec; 80(12 Suppl):2360-70. PubMed ID: 9406684
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and antigestagenic activity of mifepristone derivatives.
Hödl C; Raunegger K; Strommer R; Ecker GF; Kunert O; Sturm S; Seger C; Haslinger E; Steiner R; Strauss WS; Schramm HW
J Med Chem; 2009 Mar; 52(5):1268-74. PubMed ID: 19216549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
